Detecting leukemia relapses before they become visible: A long-term study from Dresden shows how molecular blood tests could transform blood cancer treatment.
People with MDS often face two serious problems at once: impaired blood cell production and weakening bones. Researchers in Dresden have now tested a drug that could potentially target both conditions at the same time.
| more
